The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Table 1
Demographic, clinical and laboratory characteristics of 822 CKD stage 5 patients divided into four groups defined according to levels of serum albumin and hsCRP.